Hims & Hers Health (HIMS) Operating Leases (2021 - 2026)
Hims & Hers Health (HIMS) posted Operating Leases of $157.9 million for Q1 2026, up 10.31% sequentially from $143.2 million in Q4 2025, and up 149.17% YoY from $63.4 million in Q1 2025.
Hims & Hers Health (HIMS) Operating Leases (2021 - 2026) Analysis & Trends
Hims & Hers Health has reported Operating Leases for 6 years, with the latest figure at $157.9 million in Q1 2026.
- Quarterly Operating Leases rose 149.17% year-over-year to $157.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157.9 million (up 149.17% YoY) and the FY2025 annual result came in at $143.2 million, up 1414.03% from the prior year.
- Operating Leases advanced to $157.9 million in Q1 2026 per HIMS's latest filing, from $143.2 million in the prior quarter.
- Over five years, Operating Leases peaked at $157.9 million in Q1 2026 and troughed at $2.8 million in Q3 2023.
- A 5-year average of $39.2 million and a median of $9.5 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2025: Operating Leases sank 50.88% in 2023, then surged 1414.03% in 2025.
- Over 5 years, Operating Leases stood at $3.6 million in 2022, then soared by 137.52% to $8.7 million in 2023, then advanced by 9.1% to $9.5 million in 2024, then soared by 1414.03% to $143.2 million in 2025, then grew by 10.31% to $157.9 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $157.9 million, $143.2 million, and $147.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 180.94 Mn |
| Mar 31, 2026 | 157.93 Mn |
| Dec 31, 2025 | 143.17 Mn |
| Sep 30, 2025 | 147.00 Mn |
| Jun 30, 2025 | 74.92 Mn |
| Mar 31, 2025 | 63.38 Mn |
| Dec 31, 2024 | 9.46 Mn |
| Sep 30, 2024 | 11.36 Mn |
| Jun 30, 2024 | 11.48 Mn |
| Mar 31, 2024 | 11.82 Mn |
| Dec 31, 2023 | 8.67 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 5.70 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 4.12 Mn |